1.
Vasculogenic mimicry: a new prognostic sign of human osteosarcoma
by Ren, Ke, MD
Human pathology, 2014, Vol.45 (10), p.2120-2129

2.
Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial
by van Rhee, Frits, Prof
The lancet oncology, 2014, Vol.15 (9), p.966-974
